Inovio Pharmaceuticals (INO) Earnings Date, Estimates & Call Transcripts → Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (From InvestorPlace) (Ad) Free INO Stock Alerts $12.00 -0.79 (-6.18%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 13) -$1.31 Missed By -$0.23 Consensus EPS (May. 13) -$1.08 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Inovio Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for INO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueINO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Inovio Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($1.17)($1.17)($1.17)Q2 20241($1.28)($1.28)($1.28)Q3 20241($1.18)($1.18)($1.18)Q4 20241($1.14)($1.14)($1.14)FY 20244($4.77)($4.77)($4.77)Q1 20251($1.16)($1.16)($1.16)Q2 20251($1.07)($1.07)($1.07)Q3 20251($0.99)($0.99)($0.99)Q4 20251$1.20$1.20$1.20FY 20254($2.02)($2.02)($2.02)INO Earnings Date and InformationInovio Pharmaceuticals last announced its quarterly earnings data on May 13th, 2024. The biopharmaceutical company reported ($1.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.08) by $0.23. Inovio Pharmaceuticals has generated $0.00 earnings per share over the last year. Earnings for Inovio Pharmaceuticals are expected to grow in the coming year, from ($4.66) to ($2.86) per share. Inovio Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More Inovio Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024Estimated)------- 5/13/2024Q1 2024($1.08)($1.31)($0.23)($1.31)$0.23 million- 11/9/2023Q3 2023($18.72)($12.96)+$5.76($0.05)$0.18 million$0.39 million8/9/2023Q2 2023($20.16)($18.72)+$1.44($0.13)$0.20 million$0.23 million 5/10/2023Q1 2023($20.16)($23.04)($2.88)($0.16)$0.20 million$0.11 million 3/1/2023Q4 2022($23.04)($31.68)($8.64)($0.21)$0.46 million$0.13 million 11/8/2022Q3 2022($41.76)($21.60)+$20.16($0.15)$0.53 million$9.15 million Get the Latest News and Ratings for INO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inovio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($43.20)($66.24)($23.04)($0.46)$0.52 million$0.78 million 5/10/2022Q1 2022($40.32)($51.84)($11.52)($0.36)$0.66 million$0.20 million 3/1/2022Q4 2021($47.52)($72.00)($24.48)($0.50)$0.55 million$0.84 million 11/9/2021Q3 2021($47.52)($41.76)+$5.76($0.29)$0.19 million$0.29 million 8/9/2021Q2 2021($36.00)($56.16)($20.16)($0.39)$1.21 million$0.27 million Inovio Pharmaceuticals Earnings - Frequently Asked Questions When is Inovio Pharmaceuticals's earnings date? Inovio Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on INO's earnings history. Did Inovio Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Inovio Pharmaceuticals (NASDAQ:INO) missed the analysts' consensus estimate of ($1.08) by $0.23 with a reported earnings per share (EPS) of ($1.31). Learn more on analysts' earnings estimate vs. INO's actual earnings. How can I listen to Inovio Pharmaceuticals's earnings conference call? The conference call for Inovio Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Inovio Pharmaceuticals's conference call transcript? The conference call transcript for Inovio Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Inovio Pharmaceuticals's earnings report? Inovio Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Inovio Pharmaceuticals generate each year? Inovio Pharmaceuticals (NASDAQ:INO) has a recorded annual revenue of $830,000.00. How much profit does Inovio Pharmaceuticals generate each year? Inovio Pharmaceuticals (NASDAQ:INO) has a recorded net income of -$135.12 million. INO has generated $0.00 earnings per share over the last four quarters. What is Inovio Pharmaceuticals's EPS forecast for next year? Inovio Pharmaceuticals's earnings are expected to grow from ($4.66) per share to ($2.86) per share in the next year. More Earnings Resources from MarketBeat Related Companies: TLSI Earnings UTMD Earnings ANGO Earnings RCEL Earnings SGHT Earnings GUTS Earnings PROF Earnings CERS Earnings OBIO Earnings TCMD Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:INO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
